罗氏Gazyva在自身免疫领域势头强劲，凭借三期试验胜利巩固狼疮治疗新阵地——Fierce Pharma报道

Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win  Fierce Pharma